Key Information
Source
summary/abstract
Clinical pharmacists have a critical, multifaceted role in improving the detection and management of transthyretin amyloid cardiomyopathy (ATTR-CM). In a Pharmacy Times Clinical Forum discussion, moderator Stormi Gale, PharmD, BCPS, BCCP, FHFSA, a cardiology clinical pharmacy specialist in the cardiovascular intensive care unit at Atrium Health Carolinas Medical Center, Wingate University School of Pharmacy, emphasizes how pharmacists are often the most accessible health care professionals to patients and are key in proactively detecting ATTR-CM through “red flags,” addressing medication access, and helping patients overcome operational challenges and hurdles during the treatment journey.